The upstream DUB3-mediated VDR deubiquitination can maintain the high VDR protein levels and further inhibit mitochondrial oxidative stress and microglial activation, suggesting VDR is able to regulate the PD progression with multiple targets. This evidence concerns the gene USP17L2 and Parkinson disease.